Viewing Study NCT05671757


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-25 @ 5:38 AM
Study NCT ID: NCT05671757
Status: RECRUITING
Last Update Posted: 2025-07-23
First Post: 2022-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab in Primary Antiphospholipid Syndrome
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Daratumumab View
None Anti-Phospholipid Syndrome View